These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 29390527)
21. Multivariate analysis based on the maximum standard unit value of Wang Y; Lyu D; Zhou T; Tu W; Fan L; Liu S Diagn Interv Radiol; 2023 Mar; 29(2):379-389. PubMed ID: 36988049 [TBL] [Abstract][Full Text] [Related]
22. Detection efficacy of analog [ Chen Z; Long Y; Zhang Y; Zhang B; He Q; Zhang X Eur Radiol; 2023 Mar; 33(3):2118-2127. PubMed ID: 36322193 [TBL] [Abstract][Full Text] [Related]
23. [ Moon JW; Song YH; Kim YN; Woo JY; Son HJ; Hwang HS; Lee SH Ann Nucl Med; 2024 Sep; 38(9):754-762. PubMed ID: 38795306 [TBL] [Abstract][Full Text] [Related]
24. The prediction of spread through air spaces with preoperative 18F-FDG PET/CT in cases with primary lung adenocarcinoma, its effect on the decision for an adjuvant treatment and its prognostic role. Falay O; Selçukbiricik F; Tanju S; Erus S; Kapdağli M; Cesur E; Yavuz Ö; Bulutay P; Firat P; Mandel NM; Dilege Ş Nucl Med Commun; 2021 Aug; 42(8):922-927. PubMed ID: 33795612 [TBL] [Abstract][Full Text] [Related]
25. The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30 mm. Son BY; Cho S; Yum SW; Kim K; Jheon S J Surg Oncol; 2018 Mar; 117(3):451-456. PubMed ID: 29127699 [TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of nomogram based on whole tumour size, tumour disappearance ratio on CT and SUVmax on PET in lung adenocarcinoma. Song SH; Ahn JH; Lee HY; Lee G; Choi JY; Kang J; Kim EY; Han J; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Shim YM Eur Radiol; 2016 Jun; 26(6):1538-46. PubMed ID: 26455720 [TBL] [Abstract][Full Text] [Related]
27. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection. Lee JW; Na JO; Kang DY; Lee SY; Lee SM Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385 [TBL] [Abstract][Full Text] [Related]
28. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography. Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488 [TBL] [Abstract][Full Text] [Related]
29. F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma. Noda Y; Goshima S; Kanematsu M; Watanabe H; Kawada H; Kawai N; Ono H; Bae KT Ann Nucl Med; 2016 Jan; 30(1):11-7. PubMed ID: 26337532 [TBL] [Abstract][Full Text] [Related]
30. [Value of PET/CT Combined with CT Three-dimensional Reconstruction in Distinguishing Different Pathological Subtypes of Early Lung Adenocarcinoma]. You J; Zhang G; Gao X; Chen Y; Shu Y Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):468-474. PubMed ID: 34120430 [TBL] [Abstract][Full Text] [Related]
31. Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma. Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M Ann Oncol; 2013 Sep; 24(9):2376-81. PubMed ID: 23788749 [TBL] [Abstract][Full Text] [Related]
32. Impact of rigid and nonrigid registration on the determination of 18F-FDG PET-based tumour volume and standardized uptake value in patients with lung cancer. Grgic A; Ballek E; Fleckenstein J; Moca N; Kremp S; Schaefer A; Kuhnigk JM; Rübe C; Kirsch CM; Hellwig D Eur J Nucl Med Mol Imaging; 2011 May; 38(5):856-64. PubMed ID: 21258929 [TBL] [Abstract][Full Text] [Related]
33. Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer. Meng X; Sun X; Mu D; Xing L; Ma L; Zhang B; Zhao S; Yang G; Kong FM; Yu J Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):960-6. PubMed ID: 21440998 [TBL] [Abstract][Full Text] [Related]
34. [Clinical value of (18)F-FDGPET/CT in differentiation between benign lesions and lung cancer for large shadows in patients with pneumoconiosis]. Wang Y; Zhang H; Cui X; Fang N; Zeng L; Zhang C Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Mar; 32(3):186-9. PubMed ID: 24641846 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis. Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018 [TBL] [Abstract][Full Text] [Related]
36. Value of preoperative Chen X; Li P; Zhang M; Wang X; Wang D PeerJ; 2023; 11():e15242. PubMed ID: 37138817 [TBL] [Abstract][Full Text] [Related]
37. Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery. Kim DH; Son SH; Kim CY; Hong CM; Oh JR; Song BI; Kim HW; Jeong SY; Lee SW; Lee J; Ahn BC Ann Surg Oncol; 2014 Feb; 21(2):589-96. PubMed ID: 24046125 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983 [TBL] [Abstract][Full Text] [Related]
39. F18-FDG PET-CT analyses of small peripheral adenocarcinoma of the lung. Takahashi Y; Takashima S; Watanabe S; Tomita Y; Hakucho T; Miyake C; Morimoto D; Hosoki T; Nakanishi K; Higashiyama M Acta Radiol; 2013 Mar; 54(2):164-8. PubMed ID: 23138022 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). Mirili C; Guney IB; Paydas S; Seydaoglu G; Kapukaya TK; Ogul A; Gokcay S; Buyuksimsek M; Yetisir AE; Karaalioglu B; Tohumcuoglu M Int J Clin Oncol; 2019 Feb; 24(2):168-178. PubMed ID: 30109543 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]